GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » Dividends per Share

Albert Labs International (XCNQ:ABRT) Dividends per Share : C$0.00 (TTM As of Sep. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International Dividends per Share?

Albert Labs International's dividends per share for the three months ended in Sep. 2023 was C$0.00. Its dividends per share for the trailing twelve months (TTM) ended in Sep. 2023 was C$0.00. Its Dividend Payout Ratio for the three months ended in Sep. 2023 was 0.00. As of today, Albert Labs International's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.


Albert Labs International Dividends per Share Historical Data

The historical data trend for Albert Labs International's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International Dividends per Share Chart

Albert Labs International Annual Data
Trend Dec21 Dec22
Dividends per Share
- -

Albert Labs International Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Albert Labs International's Dividends per Share

For the Biotechnology subindustry, Albert Labs International's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Albert Labs International's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Albert Labs International's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Albert Labs International's Dividend Yield % falls into.



Albert Labs International Dividends per Share Calculation

Dividends paid to per common share.


Albert Labs International  (XCNQ:ABRT) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Albert Labs International's Dividend Payout Ratio for the quarter that ended in Sep. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Sep. 2023 )/ EPS without NRI (Q: Sep. 2023 )
=0/ -0
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Albert Labs International Dividends per Share Related Terms

Thank you for viewing the detailed overview of Albert Labs International's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Albert Labs International (XCNQ:ABRT) Business Description

Traded in Other Exchanges
N/A
Address
6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6
Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International (XCNQ:ABRT) Headlines

No Headlines